Rallybio jumps on merger with Candid Therapeutics
Source: SeekingAlpha
2026-03-02 09:49:41 ET
More on Rallybio
- Seeking Alpha’s Quant Rating on Rallybio
- Historical earnings data for Rallybio
- Financial information for Rallybio
Read the full article on Seeking Alpha
For further details see:
Rallybio jumps on merger with Candid Therapeutics
Rallybio Corporation
NASDAQ: RLYB
RLYB Trading
-1.65% G/L:
$10.74 Last:
7,052 Volume:
$10.80 Open:
RLYB Latest News
RLYB Stock Data
$25,346,266
4,324,707
0.55%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
New Haven
